US6131575A
(en)
*
|
1991-01-10 |
2000-10-17 |
The Procter & Gamble Company |
Urinary incontinence device
|
WO1996000072A1
(en)
*
|
1994-06-23 |
1996-01-04 |
The Procter & Gamble Company |
Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
|
DE19517145C2
(de)
*
|
1995-05-10 |
2000-02-24 |
Hexal Pharmaforschung Gmbh |
Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
|
US6245347B1
(en)
*
|
1995-07-28 |
2001-06-12 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
US5980948A
(en)
*
|
1996-08-16 |
1999-11-09 |
Osteotech, Inc. |
Polyetherester copolymers as drug delivery matrices
|
DE19649534B4
(de)
*
|
1996-11-29 |
2004-05-06 |
Lts Lohmann Therapie-Systeme Ag |
Verpackung aus Verbundpackstoff zum Verpacken von wirkstoffhaltigen Pflastern
|
CA2281876A1
(en)
*
|
1997-02-28 |
1998-09-03 |
Minnesota Mining And Manufacturing Company |
Transdermal device for the delivery of testosterone
|
US5953885A
(en)
*
|
1997-04-08 |
1999-09-21 |
Retail Communications Corp. |
Cosmetic sampler and method of making using bulk thin film application techniques
|
US6691872B1
(en)
|
1997-04-08 |
2004-02-17 |
Aki, Inc. |
Method of making a cosmetic sampler using bulk thin film application techniques
|
US6261405B1
(en)
|
1997-06-27 |
2001-07-17 |
Noven Pharmaceuticals, Inc. |
Method and apparatus for making a patch
|
DE19728517C2
(de)
*
|
1997-07-04 |
1999-11-11 |
Sanol Arznei Schwarz Gmbh |
TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung
|
DE19728516C2
(de)
*
|
1997-07-04 |
1999-11-11 |
Sanol Arznei Schwarz Gmbh |
TTS zur Verabreichung von Levonorgestrel und gegebenenfalls Estradiol
|
US20020012694A1
(en)
*
|
1997-09-17 |
2002-01-31 |
Alfred J. Moo-Young |
Transdermal administration of ment
|
US6767902B2
(en)
|
1997-09-17 |
2004-07-27 |
The Population Council, Inc. |
Androgen as a male contraceptive and non-contraceptive androgen replacement
|
JP2001526194A
(ja)
|
1997-12-19 |
2001-12-18 |
ターロ ファーマシューティカルズ ユーエスエイ インコーポレイテッド |
局所的カルバマゼピン製剤及び使用方法
|
US7491232B2
(en)
*
|
1998-09-18 |
2009-02-17 |
Aptus Endosystems, Inc. |
Catheter-based fastener implantation apparatus and methods with implantation force resolution
|
DE19821788C1
(de)
*
|
1998-05-15 |
1999-12-02 |
Sanol Arznei Schwarz Gmbh |
Transdermales Therapeutisches System (TTS) Pergolid enthaltend
|
WO2000018339A1
(en)
*
|
1998-09-29 |
2000-04-06 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
US6475514B1
(en)
*
|
1998-12-03 |
2002-11-05 |
Andrew Blitzer |
Athletic patch
|
JP4864204B2
(ja)
|
1998-12-18 |
2012-02-01 |
アルザ・コーポレーション |
透明な経皮的ニコチン送達デバイス
|
US6242473B1
(en)
*
|
1999-01-08 |
2001-06-05 |
Maxim Pharmaceuticals, Inc. |
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
|
US6270781B1
(en)
|
1999-01-08 |
2001-08-07 |
Maxim Pharmaceuticals, Inc. |
Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
|
US6274168B1
(en)
|
1999-02-23 |
2001-08-14 |
Mylan Pharmaceuticals Inc. |
Phenytoin sodium pharmaceutical compositions
|
ES2244422T3
(es)
*
|
1999-04-01 |
2005-12-16 |
Alza Corporation |
Dispositivos para la administracion transdermica de farmacos que comprenden un deposito de poliuretano para farmacos.
|
US6417227B1
(en)
|
1999-04-28 |
2002-07-09 |
Cg And Associates |
Methods of delivery of cetyl myristoleate
|
JP4889172B2
(ja)
*
|
1999-06-11 |
2012-03-07 |
リンテック株式会社 |
水分感応性経皮吸収型製剤
|
FR2795326B1
(fr)
*
|
1999-06-28 |
2001-08-31 |
Adir |
Composition pharmaceutique solide thermoformable a liberation controlee
|
DE10001546A1
(de)
*
|
2000-01-14 |
2001-07-19 |
Beiersdorf Ag |
Verfahren zur kontinuierlichen Herstellung und Beschichtung von Selbstlebemassen auf Basis von Polyisobutylen mit mindestens einem pharmazeutischen Wirkstoff
|
US20020004065A1
(en)
|
2000-01-20 |
2002-01-10 |
David Kanios |
Compositions and methods to effect the release profile in the transdermal administration of active agents
|
DE10018834A1
(de)
*
|
2000-04-15 |
2001-10-25 |
Lohmann Therapie Syst Lts |
Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
|
US6682757B1
(en)
|
2000-11-16 |
2004-01-27 |
Euro-Celtique, S.A. |
Titratable dosage transdermal delivery system
|
KR100860822B1
(ko)
*
|
2000-12-21 |
2008-09-30 |
주식회사 엘지생활건강 |
살균, 소독력을 갖는 오염물질 제거용 부착제
|
DE10110391A1
(de)
|
2001-03-03 |
2002-09-26 |
Lohmann Therapie Syst Lts |
Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
|
EP1390383B1
(de)
*
|
2001-05-11 |
2012-02-29 |
Isis Pharmaceuticals, Inc. |
Antisense-permeationsverstärker
|
US7968119B2
(en)
*
|
2001-06-26 |
2011-06-28 |
Farrell John J |
Tamper-proof narcotic delivery system
|
US20030014947A1
(en)
*
|
2001-07-19 |
2003-01-23 |
Sarojini Deevi |
Laminated metal foil packaging material and method of making
|
IL160928A0
(en)
*
|
2001-10-19 |
2004-08-31 |
Maxim Pharm Inc |
Use of histamine to treat liver disease
|
EP1448127A1
(de)
*
|
2001-11-06 |
2004-08-25 |
Maxim Pharmaceuticals, Inc. |
Zusammensetzungen für die behandlung von infektionskrankheiten
|
WO2003090855A1
(fr)
*
|
2002-04-25 |
2003-11-06 |
Centre Pharmapeptides |
Appareil et ensemble pour l'administration d'un agent antimicrobien
|
AR033748A1
(es)
*
|
2002-05-15 |
2004-01-07 |
Thalas Group Inc |
Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
|
DE10317692A1
(de)
|
2003-04-17 |
2004-11-11 |
Lts Lohmann Therapie-Systeme Ag |
Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
|
US7306812B2
(en)
|
2003-05-09 |
2007-12-11 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7276246B2
(en)
*
|
2003-05-09 |
2007-10-02 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US8524272B2
(en)
*
|
2003-08-15 |
2013-09-03 |
Mylan Technologies, Inc. |
Transdermal patch incorporating active agent migration barrier layer
|
US20050037194A1
(en)
*
|
2003-08-15 |
2005-02-17 |
Kimberly-Clark Worldwide, Inc. |
Thermoplastic polymers with thermally reversible and non-reversible linkages, and articles using same
|
US7122052B2
(en)
*
|
2003-09-29 |
2006-10-17 |
Stout Medical Group Lp |
Integral support stent graft assembly
|
JP2007509951A
(ja)
*
|
2003-10-28 |
2007-04-19 |
ノーヴェン ファーマシューティカルズ インコーポレイテッド |
経皮的なドラッグデリバリーシステムにおける医薬品の損失及び送達を制御するための組成物及び方法
|
US20050171192A1
(en)
*
|
2003-12-11 |
2005-08-04 |
Gehlsen Kurt R. |
Use of histamine to treat bone disease
|
CA2561310C
(en)
†
|
2004-03-26 |
2013-04-23 |
Csp Technologies, Inc. |
Active film adhered to flexible packages and method thereof
|
US20050221036A1
(en)
*
|
2004-04-01 |
2005-10-06 |
The Coca-Cola Company |
Polyester composition with enhanced gas barrier, articles made therewith, and methods
|
AU2005245407B9
(en)
*
|
2004-05-12 |
2010-10-14 |
E.I. Dupont De Nemours And Company |
Films comprising a liquid-absorbant inner layer, an antimicrobial material and an impermeable outer layer
|
WO2006009975A2
(en)
*
|
2004-06-22 |
2006-01-26 |
Maxim Pharmaceuticals, Inc. |
Histamine to treat disorders affecting muscle function
|
WO2006047392A2
(en)
*
|
2004-10-21 |
2006-05-04 |
The Trustees Of Columbia University In The City Of New York |
Nicotinic-opioid synergy for analgesia
|
WO2006066244A2
(en)
|
2004-12-17 |
2006-06-22 |
Cash Alan B |
Method for extending lifespan and delaying the onset of age-related disease
|
US8545952B2
(en)
*
|
2005-06-07 |
2013-10-01 |
The Coca-Cola Company |
Polyester container with enhanced gas barrier and method
|
US7820258B2
(en)
*
|
2005-10-05 |
2010-10-26 |
The Coca-Cola Company |
Container and composition for enhanced gas barrier properties
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
DE102006026060B4
(de)
*
|
2006-01-12 |
2013-01-31 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme
|
US7740879B2
(en)
*
|
2006-01-17 |
2010-06-22 |
Harrogate Holdings |
Abuse resistant transdermal drug delivery patch
|
US8173152B2
(en)
|
2006-03-24 |
2012-05-08 |
Auxilium Us Holdings, Llc |
Stabilized compositions containing alkaline labile drugs
|
US8465759B2
(en)
*
|
2006-03-24 |
2013-06-18 |
Auxilium Us Holdings, Llc |
Process for the preparation of a hot-melt extruded laminate
|
GB2438926A
(en)
*
|
2006-06-07 |
2007-12-12 |
Paul Marshall |
Transdermal patch
|
US7790077B2
(en)
*
|
2006-09-15 |
2010-09-07 |
The Coca-Cola Company |
Pressurized tooling for injection molding and method of using
|
US8124202B2
(en)
*
|
2006-09-15 |
2012-02-28 |
The Coca-Cola Company |
Multilayer container for enhanced gas barrier properties
|
DE102006050558B4
(de)
*
|
2006-10-26 |
2009-03-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
|
KR100860824B1
(ko)
*
|
2007-07-25 |
2008-09-30 |
주식회사 엘지생활건강 |
살균, 소독력을 갖는 오염물질 제거용 부착제
|
EP2291181B9
(de)
|
2008-04-18 |
2013-09-11 |
University College Dublin National University Of Ireland, Dublin |
Captodiamine zur Behandlung von depressionartigen Symptomen
|
US20100221313A1
(en)
*
|
2008-12-01 |
2010-09-02 |
Innovative Pharmaceuticals, Llc |
Transdermal reservoir patch
|
EP2413837A4
(de)
*
|
2009-04-01 |
2013-10-23 |
Jie Zhang |
Verfahren zur behandlung von myofaszialen, muskel- oder rückenschmerzen
|
US9186334B2
(en)
|
2009-05-04 |
2015-11-17 |
Nuvo Research Inc. |
Heat assisted lidocaine and tetracaine for transdermal analgesia
|
AU2010246064A1
(en)
*
|
2009-05-04 |
2011-12-22 |
Zars Pharma, Inc. |
Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
|
KR101738650B1
(ko)
|
2009-07-21 |
2017-05-22 |
밀란 인크. |
폴리이소부틸렌계 경피 패치의 연속 제조 방법
|
CA2796575C
(en)
|
2010-04-13 |
2018-05-15 |
Relmada Therapeutics, Inc. |
Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
|
DE102010064358A1
(de)
*
|
2010-12-29 |
2012-07-05 |
Acino Ag |
Transdermales Applikationssystem mit überstehender Backingfolie
|
FR2992325B1
(fr)
*
|
2012-06-26 |
2015-05-22 |
Ab7 Innovation |
Matrice sequencee multifonctionnelle monopolymerique en polyurethane coule et procede de fabrication
|
EP2682113B1
(de)
*
|
2012-07-02 |
2018-10-31 |
Luye Pharma AG |
Verschließen wirkstoffhaltiger Laminate
|
US10028904B2
(en)
|
2014-12-04 |
2018-07-24 |
Wisconsin Alumni Research Foundation |
Transdermal cannabinoid formulations
|
US9375417B2
(en)
|
2014-12-04 |
2016-06-28 |
Mary's Medicinals LLC |
Transdermal cannabinoid formulations
|
US20170291020A1
(en)
*
|
2016-04-12 |
2017-10-12 |
Mylan Inc. |
Double disk transdermal system
|
US10653639B2
(en)
|
2016-05-16 |
2020-05-19 |
Cv Sciences, Inc. |
Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction
|
ES2950096T3
(es)
|
2016-09-22 |
2023-10-05 |
Alan B Cash |
Método para aliviar los síntomas del síndrome premenstrual
|
KR101892270B1
(ko)
*
|
2017-04-07 |
2018-08-27 |
주식회사 삼양사 |
피부자극을 최소화 할 수 있는 경피 흡수용 패취 시스템
|
KR20230131894A
(ko)
|
2021-01-14 |
2023-09-14 |
알란 비. 캐쉬 |
옥살로아세테이트를 사용한 병적 피로의 치료
|